Free Trial

JCR Pharmaceuticals (JCRRF) Short Interest Ratio & Short Volume

JCR Pharmaceuticals logo
$4.57 0.00 (0.00%)
(As of 11/20/2024 ET)

JCR Pharmaceuticals Short Interest Data

JCR Pharmaceuticals (JCRRF) has a short interest of 290,200 shares. This marks a -4.91% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 200 shares to cover all short positions.

Current Short Interest
290,200 shares
Previous Short Interest
305,200 shares
Change Vs. Previous Month
-4.91%
Dollar Volume Sold Short
$1.33 million
Short Interest Ratio
0.0 Days to Cover
Last Record Date
October 31, 2024
Today's Trading Volume
0 shares
Average Trading Volume
200 shares
Today's Volume Vs. Average
0%
Short Selling JCR Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for JCR Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

JCRRF Short Interest Over Time

JCRRF Days to Cover Over Time

JCRRF Percentage of Float Shorted Over Time

JCR Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/2024290,200 shares $1.33 million -4.9%N/A0 $4.57
10/15/2024305,200 shares $1.39 million +1.4%N/A3052 $4.57
9/30/2024301,000 shares $1.41 million +0.2%N/A0 $4.70
9/15/2024300,300 shares $1.41 million -3.0%N/A3003 $4.70
8/31/2024309,700 shares $1.33 million -12.1%N/A0 $4.30
8/15/2024352,400 shares $1.52 million -7.3%N/A0 $4.30
7/31/2024380,200 shares $1.64 million -6.1%N/A3802 $4.30
7/15/2024405,000 shares $2.11 million -21.8%N/A0 $5.22
6/30/2024517,600 shares $2.70 million +15.8%N/A0 $5.22
6/15/2024447,000 shares $2.33 million -17.8%N/A0 $5.22
5/31/2024544,000 shares $2.84 million +0.8%N/A0 $5.22
5/15/2024539,500 shares $2.82 million +5.3%N/A0 $5.22
4/30/2024512,400 shares $2.67 million -7.0%N/A0 $5.22
4/15/2024551,200 shares $2.88 million -6.7%N/A5512 $5.22
3/31/2024590,800 shares $3.66 million -6.0%N/A0 $6.20
3/15/2024628,800 shares $3.90 million -20.6%N/A0 $6.20
2/29/2024791,700 shares $4.91 million -2.7%N/A0 $6.20
2/15/2024813,800 shares $5.05 million +5.5%N/A8138 $6.20
1/15/2024726,700 shares $6.57 million -3.3%N/A0 $9.04
12/31/2023751,100 shares $6.79 million -0.1%N/A0 $9.04
12/15/2023752,000 shares $6.80 million -3.2%N/A0 $9.04
11/30/2023776,700 shares $7.02 million -5.1%N/A0 $9.04
11/15/2023818,200 shares $7.40 million +0.2%N/A0 $9.04
10/31/2023816,300 shares $7.38 million +0.6%N/A0 $9.04
10/15/2023811,100 shares $7.33 million -1.1%N/A8111 $9.04
9/30/2023820,000 shares $8.29 million -5.8%N/A8200 $10.11
9/15/2023870,600 shares $8.24 million +3.7%N/A0 $9.47
8/31/2023839,900 shares $7.95 million -1.6%N/A0 $9.47
8/15/2023853,300 shares $8.08 million -4.8%N/A0 $9.47
7/31/2023896,300 shares $8.49 million +20.9%N/A8963 $9.47
7/15/2023741,600 shares $7.04 million +13.4%N/A0 $9.49
6/30/2023654,100 shares $6.21 million -2.9%N/A6541 $9.49
6/15/2023673,300 shares $7.24 million +9.4%N/A0 $10.76
5/31/2023615,400 shares $6.62 million +53.9%N/A0 $10.76
5/15/2023400,000 shares $4.30 million +11.6%N/A0 $10.76
4/30/2023358,500 shares $3.86 million +17.5%N/A0 $10.76
4/15/2023305,000 shares $3.28 million +8.2%N/A3050 $10.76
3/31/2023281,800 shares $2.93 million +4.3%N/A2818 $10.40
3/15/2023270,200 shares $2.81 million -5.4%N/A2702 $10.40
2/28/2023285,700 shares $3.54 million -0.2%N/A0 $12.38
This company will win the AI race (Ad)

Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.
2/15/2023286,300 shares $3.54 million -10.5%N/A1431.5 $12.38
1/31/2023319,700 shares $6.15 million +11.4%N/A0 $19.24
1/15/2023287,100 shares $5.52 million -13.1%N/A0 $19.24
12/30/2022330,400 shares $6.36 million -5.9%N/A3304 $19.24
12/15/2022351,100 shares $6.76 million -65.0%N/A1.1 $19.24
11/30/20221,004,100 shares $19.32 million +120.8%N/A0 $19.24
11/15/2022454,800 shares $8.75 million +14.6%N/A0 $19.24
10/31/2022397,000 shares $7.64 million +3.9%N/A0 $19.24
10/15/2022382,200 shares $7.35 million +1.0%N/A3822 $19.24
9/30/2022378,300 shares $7.28 million +0.3%N/A3783 $19.24
9/15/2022377,200 shares $7.26 million -63.3%N/A1.3 $19.24
8/31/20221,027,200 shares $19.76 million +22.5%N/A0 $19.24
8/15/2022838,500 shares $16.13 million +39.5%N/A8385 $19.24
7/31/2022601,000 shares $11.56 million -34.2%N/A751.3 $19.24
7/15/2022912,800 shares $16.38 million +91.5%N/A0 $17.95
6/30/2022476,600 shares $8.55 million +2.1%N/A0 $17.95
6/15/2022466,800 shares $8.38 million +0.5%N/A0 $17.95
5/31/2022464,400 shares $8.34 million -8.5%N/A0 $17.95
5/15/2022507,600 shares $9.11 million -1.8%N/A0 $17.95
4/30/2022517,100 shares $9.28 million +3.8%N/A0 $17.95
4/15/2022498,400 shares $8.95 million +3.4%N/A0 $17.95
3/31/2022482,000 shares $8.65 million -14.4%N/A0 $17.95
3/15/2022563,300 shares $10.11 million -26.9%N/A0 $17.95
2/28/2022771,000 shares $13.84 million +3.4%N/A0 $17.95
2/15/2022745,500 shares $13.38 million +1.0%N/A0 $17.95
1/31/2022738,500 shares $13.26 million -23.6%N/A2461.7 $17.95
1/15/2022967,100 shares $26.98 million +43.5%N/A0 $27.90
12/31/2021674,100 shares $18.81 million +25.1%N/A0 $27.90
12/15/2021538,700 shares $15.03 million +16.6%N/A0 $27.90
11/30/2021462,000 shares $12.89 million -1.6%N/A0 $27.90
11/15/2021469,400 shares $13.10 million +11.4%N/A0 $27.90
10/29/2021421,500 shares $11.76 million -4.8%N/A0 $27.90
10/15/2021442,800 shares $12.35 million -1.3%N/A0 $27.90
9/30/2021448,400 shares $12.51 million -18.4%N/A0 $27.90
9/15/2021549,600 shares $15.33 million -36.9%N/A5496 $27.90
8/31/2021871,500 shares $24.31 million +22.7%N/A0 $27.90
8/13/2021710,100 shares $19.81 million +57.9%N/A0 $27.90
7/30/2021449,800 shares $12.55 million -7.2%N/A0 $27.90
7/15/2021484,600 shares $13.52 million -1.8%N/A0 $27.90
6/30/2021493,300 shares $13.76 million +0.7%N/A0 $27.90
6/15/2021490,100 shares $13.67 million +1.9%N/A0 $27.90
5/28/2021481,000 shares $13.42 million +16.6%N/A0 $27.90
5/14/2021412,700 shares $11.51 million -7.2%N/A0 $27.90
4/30/2021444,500 shares $12.40 million -22.4%N/A4445 $27.90
4/15/2021573,100 shares $19.40 million +51.4%N/A0 $33.85
3/31/2021378,500 shares $12.81 million +42.0%N/A0 $33.85
3/15/2021266,500 shares $9.02 million +27.6%N/A0 $33.85
2/26/2021208,900 shares $7.07 million +25.4%N/A2089 $33.85
2/12/2021166,600 shares $0.00 -33.6%N/A0 $0.00
1/29/2021251,000 shares $0.00 +48.9%N/A0 $0.00
This company will win the AI race (Ad)

Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.
1/15/2021196,800 shares $0.00 +37.4%N/A0 $0.00
12/31/2020125,700 shares $0.00 -36.1%N/A0 $0.00

JCRRF Short Interest - Frequently Asked Questions

What is JCR Pharmaceuticals' current short interest?

Short interest is the volume of JCR Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 290,200 shares of JCRRF short. Learn More on JCR Pharmaceuticals' current short interest.

Is JCR Pharmaceuticals' short interest increasing or decreasing?

JCR Pharmaceuticals saw a decline in short interest in the month of October. As of October 31st, there was short interest totaling 290,200 shares, a decline of 4.9% from the previous total of 305,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short JCR Pharmaceuticals stock?

Short selling JCRRF is an investing strategy that aims to generate trading profit from JCR Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against JCR Pharmaceuticals?

A short squeeze for JCR Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of JCRRF, which in turn drives the price of the stock up even further.

How often is JCR Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including JCRRF, twice per month. The most recent reporting period available is October, 31 2024.




This page (OTCMKTS:JCRRF) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners